Relmada Therapeutics Inc (RLMD)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: RLMD Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-09-11	2024-09-11	B Purchase	Shenouda Maged Chief Financial Officer Officer	24,120 +37.6% 2.95 USD 71,154	24,120 +37.6%	2.95	USD 71,154
2024-09-11	2024-09-11	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	51,407 +15.5% 2.99 USD 153,707	51,407 +15.5%	2.99	USD 153,707
2024-09-11	2024-09-10	B Purchase	Shenouda Maged Chief Financial Officer Officer	21,118 +49.0% 2.73 USD 57,652	21,118 +49.0%	2.73	USD 57,652
2024-09-11	2024-09-10	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	33,014 +11.0% 2.75 USD 90,789	33,014 +11.0%	2.75	USD 90,789
2024-09-11	2024-09-09	B Purchase	Shenouda Maged Chief Financial Officer Officer	8,194 +23.5% 2.55 USD 20,895	8,194 +23.5%	2.55	USD 20,895
2024-09-11	2024-09-09	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	55,579 +22.8% 2.71 USD 150,619	55,579 +22.8%	2.71	USD 150,619
2024-09-11	2024-09-09	B Purchase	Kelly Paul Edward Non-Executive Director	25,000 +13.3% 2.59 USD 64,750	25,000 +13.3%	2.59	USD 64,750
2024-09-11	2024-09-09	B Purchase	CASAMENTO CHARLES J Non-Executive Director	13,000 +inf% 2.56 USD 33,280	13,000 +inf%	2.56	USD 33,280
2024-01-31	2024-01-31	B Purchase	Ence Chuck CA and CO Officer	13,670 +54.0% 4.05 USD 55,429	13,670 +54.0%	4.05	USD 55,429
2024-01-31	2024-01-31	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	27,460 +12.7% 4.00 USD 109,752	27,460 +12.7%	4.00	USD 109,752
2024-01-31	2024-01-31	B Purchase	Shenouda Maged Chief Financial Officer Officer	6,875 +24.5% 4.06 USD 27,943	6,875 +24.5%	4.06	USD 27,943
2024-01-31	2024-01-30	B Purchase	Ence Chuck CA and CO Officer	14,500 +134.3% 3.87 USD 56,053	14,500 +134.3%	3.87	USD 56,053
2024-01-31	2024-01-30	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	40,999 +23.4% 3.90 USD 159,949	40,999 +23.4%	3.90	USD 159,949
2024-01-31	2024-01-30	B Purchase	Shenouda Maged Chief Financial Officer Officer	15,000 +115.1% 3.89 USD 58,323	15,000 +115.1%	3.89	USD 58,323
2024-01-31	2024-01-29	B Purchase	Ence Chuck CA and CO Officer	10,800 +inf% 3.65 USD 39,438	10,800 +inf%	3.65	USD 39,438
2024-01-31	2024-01-29	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	31,541 +21.9% 3.71 USD 117,036	31,541 +21.9%	3.71	USD 117,036
2024-01-31	2024-01-29	B Purchase	Shenouda Maged Chief Financial Officer Officer	10,800 +484.7% 3.65 USD 39,450	10,800 +484.7%	3.65	USD 39,450
2023-05-24	2023-05-23	B Purchase	O'Gorman Cedric Chief Medical Officer Officer	10,000 +8264.5% 3.18 USD 31,800	10,000 +8264.5%	3.18	USD 31,800
2022-12-12	2022-12-08	B Purchase	TRAVERSA SERGIO Chief Executive Officer Executive Director	55,250 +62.2% 2.10 USD 115,804	55,250 +62.2%	2.10	USD 115,804
2022-07-05	2022-07-01	S Sale	TRAVERSA SERGIO Chief Executive Officer Executive Director	4,068 -4.4% 18.32 USD 74,526	4,068 -4.4%	18.32	USD 74,526
2022-07-05	2022-07-01	S Sale	TRAVERSA SERGIO Chief Executive Officer Executive Director	8,848 -8.7% 18.45 USD 163,246	8,848 -8.7%	18.45	USD 163,246
2022-07-05	2022-07-01	S Sale	TRAVERSA SERGIO Chief Executive Officer Executive Director	839 -0.8% 18.48 USD 15,505	839 -0.8%	18.48	USD 15,505
2022-07-05	2022-06-30	S Sale	TRAVERSA SERGIO Chief Executive Officer Executive Director	10,698 -10.8% 19.01 USD 203,369	10,698 -10.8%	19.01	USD 203,369
2022-07-05	2022-06-30	S Sale	TRAVERSA SERGIO Chief Executive Officer Executive Director	5,314 -5.1% 19.37 USD 102,932	5,314 -5.1%	19.37	USD 102,932
2022-04-05	2022-04-04	PS Planned sale	Kelly Paul Edward Non-Executive Director	10,000 -5.1% 30.04 USD 300,395	10,000 -5.1%	30.04	USD 300,395
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -100.0% 29.00 USD 95,700	3,300 -100.0%	29.00	USD 95,700
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -50.0% 29.00 USD 95,700	3,300 -50.0%	29.00	USD 95,700
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -33.3% 29.00 USD 95,700	3,300 -33.3%	29.00	USD 95,700
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -25.0% 29.00 USD 95,700	3,300 -25.0%	29.00	USD 95,700
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -20.0% 29.00 USD 95,700	3,300 -20.0%	29.00	USD 95,700
2022-04-05	2022-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,300 -16.7% 29.00 USD 95,700	3,300 -16.7%	29.00	USD 95,700
2021-06-02	2021-06-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	2,480 -26.3% 33.19 USD 82,300	2,480 -26.3%	33.19	USD 82,300
2021-06-02	2021-06-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	520 -5.2% 34.08 USD 17,721	520 -5.2%	34.08	USD 17,721
2021-04-05	2021-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	1,691 -11.5% 35.04 USD 59,253	1,691 -11.5%	35.04	USD 59,253
2021-04-05	2021-04-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	1,309 -8.2% 35.93 USD 47,028	1,309 -8.2%	35.93	USD 47,028
2021-03-11	2021-03-10	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	2,983 -3.3% 35.09 USD 104,676	2,983 -3.3%	35.09	USD 104,676
2021-03-10	2021-03-10	PS Planned sale	Shenouda Maged CFO Officer	2,373 -51.6% 35.11 USD 83,313	2,373 -51.6%	35.11	USD 83,313
2021-03-11	2021-03-09	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	1,800 -1.9% 36.32 USD 65,380	1,800 -1.9%	36.32	USD 65,380
2021-03-11	2021-03-09	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	5,217 -5.3% 35.42 USD 184,789	5,217 -5.3%	35.42	USD 184,789
2021-03-11	2021-03-09	PS Planned sale	Kelly Paul Edward Non-Executive Director	1,612 -1.0% 36.33 USD 58,556	1,612 -1.0%	36.33	USD 58,556
2021-03-11	2021-03-09	PS Planned sale	Kelly Paul Edward Non-Executive Director	3,388 -2.0% 35.42 USD 119,995	3,388 -2.0%	35.42	USD 119,995
2021-03-10	2021-03-09	PS Planned sale	Shenouda Maged CFO Officer	1,800 -28.1% 36.02 USD 64,836	1,800 -28.1%	36.02	USD 64,836
2021-03-10	2021-03-09	PS Planned sale	Shenouda Maged CFO Officer	5,727 -47.2% 35.42 USD 202,857	5,727 -47.2%	35.42	USD 202,857
2021-03-10	2021-03-08	PS Planned sale	Shenouda Maged CFO Officer	100 -0.8% 35.00 USD 3,500	100 -0.8%	35.00	USD 3,500
2021-03-02	2021-03-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	3,000 -15.8% 33.87 USD 101,618	3,000 -15.8%	33.87	USD 101,618
2021-02-26	2021-02-24	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	303 -0.3% 35.55 USD 10,771	303 -0.3%	35.55	USD 10,771
2021-02-26	2021-02-24	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	4,860 -5.2% 34.70 USD 168,659	4,860 -5.2%	34.70	USD 168,659
2021-02-26	2021-02-24	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	4,837 -4.9% 33.69 USD 162,963	4,837 -4.9%	33.69	USD 162,963
2021-02-26	2021-02-24	PS Planned sale	Kelly Paul Edward Non-Executive Director	108 -0.1% 35.58 USD 3,843	108 -0.1%	35.58	USD 3,843
2021-02-26	2021-02-24	PS Planned sale	Kelly Paul Edward Non-Executive Director	2,463 -1.4% 34.64 USD 85,315	2,463 -1.4%	34.64	USD 85,315
2021-02-26	2021-02-24	PS Planned sale	Kelly Paul Edward Non-Executive Director	2,429 -1.4% 33.67 USD 81,775	2,429 -1.4%	33.67	USD 81,775
2021-02-26	2021-02-24	PS Planned sale	Shenouda Maged CFO Officer	1,400 -38.6% 34.67 USD 48,544	1,400 -38.6%	34.67	USD 48,544
2021-02-26	2021-02-24	PS Planned sale	Shenouda Maged CFO Officer	1,600 -30.6% 33.74 USD 53,985	1,600 -30.6%	33.74	USD 53,985
2021-02-16	2021-02-11	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	1,446 -1.6% 35.43 USD 51,238	1,446 -1.6%	35.43	USD 51,238
2021-02-16	2021-02-11	PS Planned sale	Shenouda Maged CFO Officer	1,428 -39.1% 35.39 USD 50,542	1,428 -39.1%	35.39	USD 50,542
2021-02-10	2021-02-10	PS Planned sale	Shenouda Maged CFO Officer	2,410 -52.0% 35.20 USD 84,825	2,410 -52.0%	35.20	USD 84,825
2021-02-10	2021-02-10	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	1,930 -2.1% 35.28 USD 68,097	1,930 -2.1%	35.28	USD 68,097
2021-02-10	2021-02-09	PS Planned sale	Shenouda Maged CFO Officer	5,359 -53.6% 35.24 USD 188,843	5,359 -53.6%	35.24	USD 188,843
2021-02-10	2021-02-09	PS Planned sale	Kelly Paul Edward Non-Executive Director	2,069 -1.3% 35.29 USD 73,005	2,069 -1.3%	35.29	USD 73,005
2021-02-10	2021-02-09	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	5,963 -6.2% 35.21 USD 209,939	5,963 -6.2%	35.21	USD 209,939
2021-02-10	2021-02-08	PS Planned sale	Shenouda Maged CFO Officer	3,603 -26.5% 35.04 USD 126,242	3,603 -26.5%	35.04	USD 126,242
2021-02-10	2021-02-08	PS Planned sale	Kelly Paul Edward Non-Executive Director	1,500 -0.9% 35.04 USD 52,560	1,500 -0.9%	35.04	USD 52,560
2021-02-10	2021-02-08	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	3,313 -3.3% 35.03 USD 116,049	3,313 -3.3%	35.03	USD 116,049
2021-02-04	2021-02-03	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	100 -0.1% 35.00 USD 3,500	100 -0.1%	35.00	USD 3,500
2021-02-04	2021-02-03	PS Planned sale	Shenouda Maged CFO Officer	100 -4.3% 35.00 USD 3,500	100 -4.3%	35.00	USD 3,500
2021-02-04	2021-02-02	PS Planned sale	TRAVERSA SERGIO CEO Executive Director	3,178 -3.5% 35.08 USD 111,470	3,178 -3.5%	35.08	USD 111,470
2021-02-04	2021-02-02	PS Planned sale	Shenouda Maged CFO Officer	3,100 -57.1% 35.04 USD 108,634	3,100 -57.1%	35.04	USD 108,634
2021-02-03	2021-02-02	PS Planned sale	Kelly Paul Edward Non-Executive Director	2,315 -1.4% 35.04 USD 81,118	2,315 -1.4%	35.04	USD 81,118
2021-02-03	2021-02-01	PS Planned sale	Kelly Paul Edward Non-Executive Director	31 -0.0% 35.00 USD 1,085	31 -0.0%	35.00	USD 1,085
2021-02-02	2021-02-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	1,663 -8.1% 33.90 USD 56,376	1,663 -8.1%	33.90	USD 56,376
2021-02-02	2021-02-01	PS Planned sale	CASAMENTO CHARLES J Non-Executive Director	1,337 -6.1% 33.30 USD 44,522	1,337 -6.1%	33.30	USD 44,522
2021-01-29	2021-01-27	PS Planned sale	Shenouda Maged CFO Officer	1,200 -35.0% 32.43 USD 38,916	1,200 -35.0%	32.43	USD 38,916
2021-01-29	2021-01-27	PS Planned sale	Shenouda Maged CFO Officer	1,800 -34.4% 31.59 USD 56,862	1,800 -34.4%	31.59	USD 56,862
2021-01-29	2021-01-27	PS Planned sale	Kelly Paul Edward Non-Executive Director	168 -0.1% 33.40 USD 5,611	168 -0.1%	33.40	USD 5,611
2021-01-29	2021-01-27	PS Planned sale	Kelly Paul Edward Non-Executive Director	2,988 -2.0% 32.89 USD 98,275	2,988 -2.0%	32.89	USD 98,275

Relmada Therapeutics Inc (RLMD)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by